CCAT2 and breast carcinoma: For instance, the study by Wu et al. (2017) evaluated the high levels of lncRNA CCAT2 in breast cancer and downregulation of lncRNA CCAT2 arrested the cells in the G0/G1 phase and promoted apoptosis by modulating the TGF-β signalling pathway (Wu et al., 2017).